|
|
| Research article summary (published 30 Aug 2009): |
Baseline and 6-month B-type natriuretic peptide changes are independent predictors of events in patients with advanced heart failure awaiting cardiac transplantation.
Full Abstract
OBJECTIVE: To assess the prognostic role of B-type natriuretic peptide (BNP) measured at baseline and after 6 months in advanced heart failure patients, candidates for heart transplantation. METHODS: Ninety-nine patients with BNP evaluation (mean age 50.8 years, 85% men) were admitted in the heart transplantation waiting list; 39% were in New York Heart Association functional class IV; with hemodynamic patterns of severe heart failure, the cause was ischemic in 45% and idiopathic in 44%. In order to identify more severe patients, BNP values and changes at 6 months were dichotomized according to their upper tertile (>1100 and >or=70 pg/ml, respectively). RESULTS: Median baseline BNP was 719 pg/ml. After a median of 45 months, 40 events were observed (three cardiac assist device implants, 16 urgent heart transplantations, 13 sudden deaths and eight deaths from heart failure). The event rate was 10.0 and 32.3 per 100 person-years in patients with low and high BNP, respectively. In a bivariable Cox regression, BNP at entry in the list and change in BNP at 6 months were independent predictors of events, with hazard ratios of 4.10 (95% confidence interval 2.14-7.88, P<0.001) and 4.55 (95% confidence interval 2.36-8.80, P<0.001), respectively. Furthermore, the risk increased from neither BNP/BNP change, to one of them and to both of them present. CONCLUSION: Both high baseline and further increase in BNP levels during midterm follow-up are strong predictors of events in patients with advanced heart failure awaiting heart transplantation.
Author information
Author/s: Campana, Carlo (C); Pasotti, Michele (M); Klersy, Catherine (C); Alessandrino, Giuseppe (G); Albertini, Riccardo (R); Magrini, Giulia (G); Ghio, Stefano (S); Tavazzi, Luigi (L);
Affiliation: Department of Cardiology, Clinical Epidemiology and Biometry Service, Laboratory of Clinical Chemistry, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. unita.sc(-atsign-)smatteo.pv.it
Journal and publication information
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal: Journal of cardiovascular medicine (Hagerstown, Md.) (J Cardiovasc Med (Hagerstown)), published in United States. (Language: eng)
Reference: 2009-Sep; vol 10 (issue 9) : pp 671-6
Dates: Created 2009/07/31; Completed 2009/09/08;
PMID: 19444135, status: MEDLINE (last retrieval date: 9/8/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- A change in N-terminal pro-brain natriuretic peptide is predictive of outcome in patients with advanced heart failure.
2 Oct 2006 - Prognostic information provided by serial measurements of brain natriuretic peptide in heart failure.
30 Dec 2003 - How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review.
17 Mar 2005 - Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure.
30 Aug 2000 - B-type natriuretic peptide levels predict event-free survival in patients with implantable cardioverter defibrillators.
3 Oct 2006 - Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure.
29 Nov 2001 - Prognostic threshold levels of NT-proBNP testing in primary care.
21 Nov 2008 - Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
11 May 2008 - Decreased plasma concentration of brain natriuretic peptide as a potential indicator of cardiac recovery in patients supported by mechanical circulatory assist systems.
29 Nov 2001 - Serum adiponectin level as an independent predictor of mortality in patients with congestive heart failure.
29 Apr 2007
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.